Skip to main content

MoneyWorks4Me

Bacil Pharma informs about quarterly statement on investor complaints

19 Oct 2016 Evaluate

Bacil Pharma has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1882.40
Dr. Reddys Labs. 1379.95
Cipla 1409.55
Lupin 2015.10
Zydus Lifesciences 1199.20
View more..